Skip to results
Modify your search
NARROW
1-13 of 13
Authors: Aaron Mammoser
Sort by
Journal Article
A pilot survey into the landscape of neuro-oncology care in the community
Christine Lu-Emerson and others
The Oncologist, Volume 30, Issue 3, March 2025, oyaf047, https://doi.org/10.1093/oncolo/oyaf047
Published: 31 March 2025
Journal Article
CTIM-25. PHASE2B/3 STUDY OF NEOANTIGEN-SPECIFIC T CELL IMMUNOTHERAPY IN NEWLY DIAGNOSED O6 – METHYLGUANINE METHYLTRANSFERASE UNMETHYLATED (MGMT -) GLIOBLASTOMA
Tolga Tuncer and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii91, https://doi.org/10.1093/neuonc/noae165.0358
Published: 11 November 2024
Journal Article
DISP-04. SEX DIFFERENCES IN LUNG CANCER BRAIN METASTASES ADVERSE EVENTS
Mantas Dmukauskas and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii147, https://doi.org/10.1093/neuonc/noae165.0578
Published: 11 November 2024
Journal Article
DISP-06. THE IMPACT OF SOCIAL DETERMINANTS OF HEALTH ON TREATMENT DELAYS FOR GLIOBLASTOMA
Gino Cioffi and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii147–viii148, https://doi.org/10.1093/neuonc/noae165.0580
Published: 11 November 2024
Journal Article
CTNI-17. A MULTI-INSTITUTIONAL RANDOMIZED CLINICAL TRIAL COMPARING ASSAY - GUIDED CHEMOTHERAPY WITH PHYSICIAN-CHOICE TREATMENT FOR RECURRENT HIGH-GRADE GLIOMA (NCT03632135)
Tulika Ranjan and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii73–vii74, https://doi.org/10.1093/neuonc/noac209.283
Published: 14 November 2022
Journal Article
Neuro-oncology at the American Society for Clinical Oncology 2022 Annual Meeting
Rimas V Lukas and others
Neuro-Oncology Practice, Volume 9, Issue 6, December 2022, Pages 552–558, https://doi.org/10.1093/nop/npac071
Published: 10 September 2022
Journal Article
NCMP-03. INTRATHECAL TRASTUZUMAB TREATMENT OF HER-2 POSITIVE LEPTOMENINGEAL BREAST CANCER: THE UNIVERSITY OF MICHIGAN EXPERIENCE
Kelsey Peters and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii123, https://doi.org/10.1093/neuonc/noaa215.515
Published: 09 November 2020
Journal Article
First in Human Phase I Trial of Dual Vector (HSV1-TK, Flt3L) Immunotherapy For The Treatment of Newly Diagnosed High-Grade Glioma: Initial Results
Daniel A Orringer and others
in
Neurosurgery
Neurosurgery, Volume 66, Issue Supplement_1, September 2019, nyz310_152, https://doi.org/10.1093/neuros/nyz310_152
Published: 20 August 2019
Journal Article
TRLS-07. BRAINSTORM: OUTCOMES FROM A MULTI-INSTITUTIONAL PHASE I/II STUDY OF RRx-001 IN COMBINATION WITH WHOLE BRAIN RADIATION THERAPY FOR PATIENTS WITH BRAIN METASTASES
Michelle Kim and others
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i9–i10, https://doi.org/10.1093/noajnl/vdz014.040
Published: 12 August 2019
Journal Article
QLIF-23. FUNCTIONAL OUTCOME, SYMPTOM BURDEN AND SURVIVAL VARY BY MOLECULAR SUBGROUP IN PATIENTS WITH ANAPLASTIC GLIOMA
Michelle Kim and others
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi160, https://doi.org/10.1093/neuonc/now212.666
Published: 07 November 2016
Journal Article
AT-32A PHASE I DOSE-ESCALATION STUDY OF GEMCITABINE PLUS STANDARD RADIATION THERAPY FOR MALIGNANT HIGH GRADE GLIOMAS
Get access
Michelle Kim and others
Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Page v15, https://doi.org/10.1093/neuonc/nou237.32
Published: 01 November 2014
Chapter
Published: 01 August 2016
Chapter
Infiltrative Astrocytomas: WHO Grade II—Diffuse Astrocytoma; WHO Grade III—Anaplastic Astrocytoma
Get access
Aaron Mammoser
Published: 01 August 2016
Advertisement
Advertisement